We're Hiring!

We're Hiring!
linkedin instagram twitter

01Home

Open Sub Nav

Open Sub Nav

01Pipeline

01Our Team

01Investors & Media

01Careers

01Contact

Investors & Media

News

April 5, 2024

NGM Bio Announces Closing of Tender Offer

Learn More
→
March 19, 2024

NGM Bio to Present Two Posters Highlighting Clinical Data from the Ongoing Phase 1/2 Clinical Trial of NGM707, a Dual ILT2/ILT4 Antagonist Antibody Product Candidate, at AACR 2024 Annual Meeting

Learn More
→
March 11, 2024

NGM Bio Provides Recent Business Highlights and Reports Fourth Quarter and Full Year 2023 Financial Results

Learn More
→
February 26, 2024

NGM Bio Has Entered into a Definitive Agreement and Plan of Merger with Certain Affiliates of The Column Group, LP

Learn More
→
February 20, 2024

NGM Bio to Participate in the Cowen 44th Annual Health Care Conference

Learn More
→
January 17, 2024

NGM Bio to Participate in the B. Riley Securities 4th Annual Oncology Conference

Learn More
→
January 9, 2024

NGM Bio Announces New Clinical Data from Ongoing Trial of NGM707 in Advanced Solid Tumors and Outlines Evolved Strategy for Aldafermin and NGM120 to Focus on Rare Conditions with Significant Unmet Need

Learn More
→

Contact Information

investor relations

ir@ngmbio.com

media relations

media@ngmbio.com

Toolkit

RSS

RSS